Stefan Oelrich

Stefan Oelrich

Corporate Officer/Principal at BAYER AG
58 year
Health Technology
Commercial Services
Consumer Services

Profile

Stefan Oelrich is currently Director at Vividion Therapeutics, Inc., President-Pharmaceuticals Division at Bayer AG since 2018, Member-Management Board at American Chamber of Commerce in Germany eV, Advisor at Longwood Fund Management LLC, Member-Supervisory Board at Berlin Institute of Health since 2016, and Member-Supervisory Board at Charité - Universitätsmedizin Berlin since 2020.
Former roles include Executive VP-Diabetes & Cardiovascular at Sanofi from 2011 to 2018, Senior Vice President & General Manager at Women's Healthcare LLC (Florida), and President at Bayer Pharma AG.

Stefan Oelrich active positions

CompaniesPositionStart
BAYER AG Corporate Officer/Principal 2018-10-31
Berlin Institute of Health
Director/Board Member 2015-12-31
Director/Board Member -
Director/Board Member -
Consultant / Advisor -
Director/Board Member 2019-12-31

Former positions of Stefan Oelrich

CompaniesPositionEnd
SANOFI Corporate Officer/Principal 2018-09-29
President -
Corporate Officer/Principal -
See the detail of Stefan Oelrich's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Finance

Health Technology

Health Services

Berlin Institute of Health

  1. Stock Market
  2. Insiders
  3. Stefan Oelrich